These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24953334)

  • 1. Preclinical evidence that SSR128129E--a novel small-molecule multi-fibroblast growth factor receptor blocker--radiosensitises human glioblastoma.
    Ader I; Delmas C; Skuli N; Bonnet J; Schaeffer P; Bono F; Cohen-Jonathan-Moyal E; Toulas C
    Eur J Cancer; 2014 Sep; 50(13):2351-9. PubMed ID: 24953334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor vasculature is regulated by FGF/FGFR signaling-mediated angiogenesis and bone marrow-derived cell recruitment: this mechanism is inhibited by SSR128129E, the first allosteric antagonist of FGFRs.
    Fons P; Gueguen-Dorbes G; Herault JP; Geronimi F; Tuyaret J; Frédérique D; Schaeffer P; Volle-Challier C; Herbert JM; Bono F
    J Cell Physiol; 2015 Jan; 230(1):43-51. PubMed ID: 24760775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1 alpha and survivin in U87 cells.
    Lanvin O; Monferran S; Delmas C; Couderc B; Toulas C; Cohen-Jonathan-Moyal E
    Eur J Cancer; 2013 Sep; 49(13):2884-91. PubMed ID: 23747271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
    Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
    Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α Pathway.
    Gouazé-Andersson V; Delmas C; Taurand M; Martinez-Gala J; Evrard S; Mazoyer S; Toulas C; Cohen-Jonathan-Moyal E
    Cancer Res; 2016 May; 76(10):3036-44. PubMed ID: 26896280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
    Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
    Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.
    Skuli N; Monferran S; Delmas C; Favre G; Bonnet J; Toulas C; Cohen-Jonathan Moyal E
    Cancer Res; 2009 Apr; 69(8):3308-16. PubMed ID: 19351861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
    Hierro C; Rodon J; Tabernero J
    Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of fibroblast growth factor receptor 1 expression in human glioblastoma cell contributes to the cell growth suppression].
    Yamada SM; Yamaguchi F; Morrison RS; Takahashi H; Teramoto A
    No To Shinkei; 1998 Dec; 50(12):1101-5. PubMed ID: 9989355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling.
    Herbert C; Schieborr U; Saxena K; Juraszek J; De Smet F; Alcouffe C; Bianciotto M; Saladino G; Sibrac D; Kudlinzki D; Sreeramulu S; Brown A; Rigon P; Herault JP; Lassalle G; Blundell TL; Rousseau F; Gils A; Schymkowitz J; Tompa P; Herbert JM; Carmeliet P; Gervasio FL; Schwalbe H; Bono F
    Cancer Cell; 2013 Apr; 23(4):489-501. PubMed ID: 23597563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.
    Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A
    Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Characterization of the Interaction of the Fibroblast Growth Factor Receptor with a Small Molecule Allosteric Inhibitor.
    Kappert F; Sreeramulu S; Jonker HRA; Richter C; Rogov VV; Proschak E; Hargittay B; Saxena K; Schwalbe H
    Chemistry; 2018 Jun; 24(31):7861-7865. PubMed ID: 29656465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.
    Eshleman JS; Carlson BL; Mladek AC; Kastner BD; Shide KL; Sarkaria JN
    Cancer Res; 2002 Dec; 62(24):7291-7. PubMed ID: 12499272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
    Bono F; De Smet F; Herbert C; De Bock K; Georgiadou M; Fons P; Tjwa M; Alcouffe C; Ny A; Bianciotto M; Jonckx B; Murakami M; Lanahan AA; Michielsen C; Sibrac D; Dol-Gleizes F; Mazzone M; Zacchigna S; Herault JP; Fischer C; Rigon P; Ruiz de Almodovar C; Claes F; Blanc I; Poesen K; Zhang J; Segura I; Gueguen G; Bordes MF; Lambrechts D; Broussy R; van de Wouwer M; Michaux C; Shimada T; Jean I; Blacher S; Noel A; Motte P; Rom E; Rakic JM; Katsuma S; Schaeffer P; Yayon A; Van Schepdael A; Schwalbe H; Gervasio FL; Carmeliet G; Rozensky J; Dewerchin M; Simons M; Christopoulos A; Herbert JM; Carmeliet P
    Cancer Cell; 2013 Apr; 23(4):477-88. PubMed ID: 23597562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor signaling affects vascular outgrowth and is required for the maintenance of blood vessel integrity.
    De Smet F; Tembuyser B; Lenard A; Claes F; Zhang J; Michielsen C; Van Schepdael A; Herbert JM; Bono F; Affolter M; Dewerchin M; Carmeliet P
    Chem Biol; 2014 Oct; 21(10):1310-1317. PubMed ID: 25200605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
    André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
    Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
    Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
    Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.